Washington, D.C. – After thoughtful consideration of the petition, public comments, and petitioner responses, the Board of Pharmacy Specialties (BPS) Board of Directors voted to not approve Pharmacogenomics as a new pharmacy specialty certification. BPS received the petition to recognize
Washington, D.C. – The Board of Pharmacy Specialties (BPS) is accepting applications from Board-Certified Pain Management Pharmacists (BCPMPs) to serve on the BPS Pain Management Pharmacy Specialty Council for a term beginning in January 2027. Up to three BCPMP positions
Washington, D.C. – The Board of Pharmacy Specialties (BPS) is proud to announce the 2026 BPS Ambassadors with their video stories sharing their journey with BPS Board Certification. The five board-certified pharmacists selected to join the BPS Ambassadors are: Kimmy
Washington, D.C. – The Board of Pharmacy Specialties (BPS) and the International Pharmaceutical Federation Foundation for Education and Research (FIP Foundation) announce the recipient of the 2026 FIP Foundation Research Grant, sponsored by BPS, as Bee Yean Low, BPharm (Hons),
Washington, D.C. – The Board of Pharmacy Specialties (BPS) shares that federal legislation enacted on July 4, 2025, expanded the use of 529 savings plans to include qualified postsecondary credentialing expenses, including BPS Board Certification. The 529 savings plan expansion
Washington, D.C. – The Board of Pharmacy Specialties (BPS) announces Taylor Camille Altidor, PharmD, MHSA as the 2026-2027 William Ellis Executive Fellow, part of the American Pharmacists Association (APhA) Executive Postgraduate Training Cohort. In 2025, the BPS Board of Directors